Insider Activity of David W. Hanna, Trustee of the David William Hanna Trust dated October 30, 1989
Biography of David W. Hanna, Trustee of the David William Hanna Trust dated October 30, 1989
No biography is available at this moment.
No biography is available at this moment.
| 2025-12-05 | Butterfly Network, Inc. BFLY | 200,000 0.0791% | $3.06 | $611,300 | +0.11% | |||
| 2025-12-05 | Biglari Holdings Inc. BH | Chairman and CEO | 1,465 0.0475% | $306.90 | $449,609 | -0.51% | ||
| 2025-12-05 | Sale | Cytokinetics, Incorporated CYTK | EVP, Chief Commercial Officer | 52,486 0.0443% | $65.95 | $3.46M | -0.42% | |
| 2025-12-05 | Sale | DocuSign, Inc. DOCU | director | 363 0.0002% | $64.50 | $23,414 | +1.81% | |
| 2025-12-05 | Sale | Dominari Holdings Inc. DOMH | COO | 140,000 0.8589% | $3.82 | $534,254 | +1.94% | |
| 2025-12-05 | Sale | Dynatrace, Inc. DT | director | 253 <0.0001% | $44.24 | $11,193 | +0.43% | |
| 2025-12-05 | Sale | Dyne Therapeutics, Inc. DYN | Chief Medical Officer | 880 0.0006% | $20.72 | $18,234 | -2.12% | |
| 2025-12-05 | Sale | Dyne Therapeutics, Inc. DYN | Chief Commercial Officer | 144 0.0001% | $20.72 | $2,984 | -2.12% | |
| 2025-12-05 | Sale | Dyne Therapeutics, Inc. DYN | CEO & President | 2,662 0.0019% | $20.72 | $55,157 | -2.12% | |
| 2025-12-05 | Sale | Enanta Pharmaceuticals, Inc. ENTA | See Remarks | 323 0.0015% | $14.23 | $4,596 | +2.6% | |
| 2025-12-05 | Sale | Enanta Pharmaceuticals, Inc. ENTA | See Remarks | 542 0.0025% | $14.23 | $7,713 | +2.6% | |
| 2025-12-05 | Sale | Enanta Pharmaceuticals, Inc. ENTA | Chief Medical Officer | 798 0.0036% | $14.23 | $11,356 | +2.6% | |
| 2025-12-05 | Sale | Enanta Pharmaceuticals, Inc. ENTA | Chief Product Strategy Officer | 2,106 0.0096% | $14.23 | $29,968 | +2.6% | |
| 2025-12-05 | Sale | Enanta Pharmaceuticals, Inc. ENTA | Chief Business Officer | 1,394 0.0064% | $14.23 | $19,837 | +2.6% | |
| 2025-12-05 | Sale | Enanta Pharmaceuticals, Inc. ENTA | Chief Scientific Officer | 2,390 0.0109% | $14.23 | $34,010 | +2.6% | |
| 2025-12-05 | Sale | Enanta Pharmaceuticals, Inc. ENTA | President and CEO | 4,743 0.0217% | $14.23 | $67,493 | +2.6% | |
| 2025-12-05 | Sale | Fennec Pharmaceuticals Inc. FENC | director | 10,000 0.0362% | $7.54 | $75,400 | +0.13% | |
| 2025-12-05 | Sale | Five9, Inc. FIVN | President | 700 0.0009% | $20.53 | $14,371 | +0.58% | |
| 2025-12-05 | Sale | Fabrinet FN | director | 500 0.0014% | $482.11 | $241,057 | -0.79% | |
| 2025-12-05 | Sale | IES Holdings, Inc. IESC | Executive Chairman | 3,774 0.0186% | $420.24 | $1.59M | +1.99% |